Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Baxter International Inc. BAX
$42.40
-$0.96 (-2.27%)
На 18:00, 12 мая 2023
+121.96%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
21455627071.00000000
-
week52high
77.08
-
week52low
37.35
-
Revenue
15113000000
-
P/E TTM
-28
-
Beta
0.55882300
-
EPS
-4.84000000
-
Last Dividend
1.16000000
-
Next Earnings Date
26 июл 2023 г. в 13:30
Описание компании
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Sell | Sell | 03 авг 2022 г. |
| Raymond James | Outperform | Outperform | 29 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 29 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 19 июл 2022 г. |
| Stifel | Buy | Buy | 18 июл 2022 г. |
| Barclays | Overweight | 18 окт 2022 г. | |
| Jefferies | Hold | 12 окт 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Goldman Sachs | Sell | Sell | 03 ноя 2022 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 28 окт 2022 г. |
| Raymond James | Outperform | Outperform | 28 окт 2022 г. |
| Keybanc | Overweight | Overweight | 28 окт 2022 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 09 янв 2023 г. |
| Morgan Stanley | Equal-Weight | Overweight | 06 янв 2023 г. |
| Raymond James | Market Perform | Outperform | 05 янв 2023 г. |
| B of A Securities | Neutral | Buy | 03 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Mason Jeanne K | D | 0 | 19826 | 17 янв 2023 г. |
| Mason Jeanne K | D | 19826 | 19826 | 17 янв 2023 г. |
| Mason Jeanne K | D | 39652 | 19825 | 17 янв 2023 г. |
| Mason Jeanne K | D | 126231 | 59477 | 17 янв 2023 г. |
| Mason Jeanne K | A | 185708 | 59477 | 17 янв 2023 г. |
| Borzi James W | D | 11822 | 4649 | 01 сент 2022 г. |
| Rosenbloom David S. | A | 33442 | 33442 | 01 июн 2022 г. |
| Rosenbloom David S. | A | 41576 | 7636 | 01 июн 2022 г. |
| Rosenbloom David S. | A | 33940 | 33940 | 01 июн 2022 г. |
| WILVER PETER M | A | 2481 | 2481 | 10 мая 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 14292500 | -120164 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 10455400 | -38824 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 5352000 | -25481 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 4371710 | -20063 | 31 авг 2020 г. |
| Fidelity Contrafund | 5642270 | -441992 | 31 июл 2020 г. |
| Fidelity 500 Index Fund | 4532440 | -4906 | 31 июл 2020 г. |
| Vanguard Dividend Growth Fund | 9409750 | -461821 | 30 июн 2020 г. |
| MS INVF Global Brands | 7997800 | 433097 | 30 июн 2020 г. |
| Vanguard Health Care Fund | 5007540 | 0 | 30 июн 2020 г. |
| Caisse de depot et Placement du Quebec | 6825970 | 3121700 | 31 дек 2019 г. |
Новостная лента
Baxter to sell its BioPharma business for $4.25 billion to Advent International, Warburg Pincus as part of ‘transformation journey'
Market Watch
08 мая 2023 г. в 10:14
Shares of Baxter International Inc. BAX rose 1.2% in premarket trading Monday, after the health care products company announced an agreement to divest its BioPharma Solutions business to private-equity investor Advent International and Warburg Pincus. Under terms of the agreement, Baxter will receive $4.25 billion in cash, which the company plans to use to pay down debt.
BAX vs. SYK: Which Stock Should Value Investors Buy Now?
Zacks Investment Research
02 мая 2023 г. в 12:57
Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Baxter International Inc. (BAX) Q1 2023 Earnings Call Transcript
Seeking Alpha
27 апр 2023 г. в 12:11
Baxter International Inc. (BAX) Q1 2023 Earnings Call Transcript.
Are Investors Undervaluing Baxter International (BAX) Right Now?
Zacks Investment Research
25 апр 2023 г. в 11:29
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Baxter (BAX) to Post Q1 Earnings: What's in the Offing?
Zacks Investment Research
20 апр 2023 г. в 08:23
Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products might have boosted sales.